DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Zeiser R, Polverelli N, Ram R. et al; REACH3 Investigators.
Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease.
N Engl J Med 2021;
385 (03) 228-238
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.